In vivo loss of tumorigenicity in a patient-derived orthotopic xenograft mouse model of ependymoma
IntroductionEpendymomas (EPN) are the third most common malignant brain cancer in children. Treatment strategies for pediatric EPN have remained unchanged over recent decades, with 10-year survival rates stagnating at just 67% for children aged 0-14 years. Moreover, a proportion of patients who surv...
Main Authors: | Jacqueline P. Whitehouse, Hilary Hii, Chelsea Mayoh, Marie Wong, Pamela Ajuyah, Paulette Barahona, Louise Cui, Hetal Dholaria, Christine L. White, Molly K. Buntine, Jacob Byrne, Keteryne Rodrigues da Silva, Meegan Howlett, Emily J. Girard, Maria Tsoli, David S. Ziegler, Jason M. Dyke, Sharon Lee, Paul G. Ekert, Mark J. Cowley, Nicholas G. Gottardo, Raelene Endersby |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1123492/full |
Similar Items
-
A Novel Orthotopic Patient-Derived Xenograft Model of Radiation-Induced Glioma Following Medulloblastoma
by: Jacqueline P. Whitehouse, et al.
Published: (2020-10-01) -
Editorial: Bench to bedside: translating pre-clinical research into clinical trials for childhood brain tumors
by: Raelene Endersby, et al.
Published: (2023-08-01) -
Advances in CAR T cell immunotherapy for paediatric brain tumours
by: Padmashree Rao, et al.
Published: (2022-11-01) -
Chimeric Antigen Receptor T cell Therapy and the Immunosuppressive Tumor Microenvironment in Pediatric Sarcoma
by: Rachael L. Terry, et al.
Published: (2021-09-01) -
Long-term outcomes of symptomatic optic pathway glioma: 32-year experience at a single Western Australian tertiary pediatric oncology center
by: Revathi Rajagopal, et al.
Published: (2023-07-01)